A breakthrough smartwatch application designed for people with epilepsy may significantly improve seizure monitoring and emergency response, according to new medical research published in Neurology Open Access. The innovative app, known as EpiWatch, demonstrated highly accurate detection of tonic-clonic seizures, also referred to as grand mal seizures, offering new hope for patients and caregivers.
Researchers found that the smartwatch app successfully identified nearly every major seizure during clinical testing while producing far fewer false alarms than many currently available seizure detection devices. Experts believe this advancement could help lower the risk of severe complications, including sudden unexpected death in epilepsy, commonly known as SUDEP.
The recent study evaluated the performance of the EpiWatch app among 242 children and adults diagnosed with epilepsy. Participants involved in the research either had a history of tonic-clonic seizures or were considered at high risk for developing them.
During the monitoring period, participants wore smartwatches equipped with the app while also being supervised through electroencephalogram (EEG) devices in a specialized hospital epilepsy unit. Researchers monitored patients for more than 16,000 total hours.
The findings were highly encouraging.
Out of 47 tonic-clonic seizures recorded during the study, the app correctly detected 46 episodes. Researchers noted that the only missed seizure occurred because a caregiver was physically restraining the patient’s arm at the time, which interfered with motion detection.
The smartwatch app achieved an overall seizure detection accuracy rate of 98%, outperforming many existing wearable seizure-monitoring systems that typically report detection rates between 76% and 94%.
One of the biggest concerns with seizure alert devices is the number of false alarms they generate. Frequent incorrect alerts can frustrate users, reduce trust in the technology, and discourage long-term use.
The EpiWatch app demonstrated a major improvement in this area.
Researchers reported only 56 false alarms throughout the entire monitoring period, which averages approximately one false alert every 12 days. According to the study, this represents about a 90% reduction in false alarms compared to other seizure detection devices currently available.
Most participants experienced no false alarms at all:
Some false alerts occurred during repetitive arm movements such as playing video games or similar activities.
Medical experts believe the reduced false alarm rate could encourage more people to consistently use wearable seizure-monitoring technology.
Tonic-clonic seizures are among the most serious forms of epilepsy-related episodes. These seizures can involve violent muscle contractions, loss of consciousness, breathing difficulties, and temporary airway obstruction.
For individuals who experience uncontrolled tonic-clonic seizures, the risk of SUDEP remains a major concern. SUDEP refers to sudden unexpected death in people with epilepsy where no other clear cause is identified.
Patients who sleep alone or do not have immediate caregiver supervision may face higher risks during nighttime seizures. Early seizure detection technology can alert caregivers or family members so they can provide first aid or seek emergency medical assistance quickly.
Dr. James Wheless, director of the Neuroscience Institute and Le Bonheur Comprehensive Epilepsy Program at Le Bonheur Children's Hospital in Memphis, Tennessee, emphasized the importance of reliable monitoring tools in improving patient safety.
According to Wheless, wearable seizure-detection devices can play an important role in helping caregivers respond rapidly during potentially dangerous seizures. However, he also noted that excessive false alarms have historically limited the effectiveness and acceptance of many monitoring systems.
Another advantage of smartwatch-based seizure detection is the familiar appearance of wearable technology. Traditional seizure-monitoring devices can sometimes appear medical or intrusive, which may discourage regular use among patients.
A standard smartwatch, however, blends naturally into daily life.
Researchers believe that using a common consumer-style wearable device may help reduce the social stigma often associated with medical monitoring equipment. This could encourage individuals with epilepsy, especially younger users, to wear seizure-detection devices consistently.
Long-term adoption is critical because seizure monitoring only works when the device is actively being worn.
The success of the EpiWatch study reflects a larger trend in healthcare technology. Smartwatches and wearable devices are increasingly being used to monitor heart rate, sleep quality, physical activity, blood oxygen levels, and now neurological conditions such as epilepsy.
Artificial intelligence and motion-tracking technologies continue to improve, making wearable medical devices more accurate and accessible than ever before.
As wearable health technology advances, researchers expect future devices to offer even more sophisticated monitoring capabilities, including earlier seizure prediction, personalized alerts, and remote physician tracking.
For people living with epilepsy, these innovations could lead to improved safety, greater independence, and better quality of life.
Although the findings are promising, researchers acknowledge that additional studies will be necessary before smartwatch seizure detection becomes a standard part of epilepsy care worldwide.
Future research will likely focus on testing the app in home environments over longer periods of time and among larger patient populations. Scientists also aim to improve detection of other seizure types beyond tonic-clonic episodes.
The current study was funded by EpiWatch Inc., the developer behind the smartwatch application.
Medical professionals stress that wearable seizure-monitoring apps should not replace professional medical evaluation or prescribed epilepsy treatment plans. Instead, these tools are intended to support patients and caregivers by providing faster awareness and emergency response during seizures.
The EpiWatch smartwatch app represents an important step forward in epilepsy care and seizure detection technology. By accurately identifying tonic-clonic seizures while minimizing false alarms, the wearable app may help improve patient safety and support quicker caregiver intervention during emergencies.
As smartwatch-based healthcare tools continue to evolve, wearable seizure-monitoring technology could become an increasingly valuable resource for people living with epilepsy around the world.
With additional research and continued technological improvements, devices like EpiWatch may eventually help reduce epilepsy-related complications and provide greater peace of mind for both patients and families.
This article is intended for informational and educational purposes only. It does not provide medical advice, diagnosis, or treatment. Individuals should consult a qualified healthcare professional regarding any medical condition or healthcare decision. Study findings discussed in this article reflect general research data and may not apply to every individual case.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.